Geneva, June 20 -- International Clinical Trials Registry received information related to the study (NCT07019155) titled 'Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants' on June 12.
Study Type: Observational
Primary Sponsor: National Cancer Institute (NCI)
Condition:
Germline Mutation
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Recruitment Status: Not recruiting
Date of First Enrollment: June 18, 2025
Target Sample Size: 510
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07019155
Published by HT Digital Content Services with permission from Health Daily Digest....